ReviewBiotechnology for biofuels and bioproducts2025
Progress and prospects in metabolic engineering approaches for isoprenoid biosynthesis in microalgae.
Review in Biotechnology for biofuels and bioproducts, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- The Mevalonate Pathway: Innovations, Applications, and Challenges in Biotechnology with Emphasis on Fungal Biology.Journal of fungi (Basel, Switzerland) · 2026Review
- Insights into transcriptomics and metabolic engineering of microalgal systems for enhancing industrial and environmental applications.World journal of microbiology & biotechnology · 2026Review
- Review
- Engineering Microalgae for Enhanced Astaxanthin Production: Integrating Metabolic Pathways and Nano-Biotechnologies.Marine drugs · 2025Review
- Application of salicylic acid and silicon can enhance drought stress tolerance in Scrophularia striata L.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Isoprenoids constitute a large and various number of bio-compounds, with many profitable applications in pharmaceutical, nutraceutical, and industrial fields. The complexity of isoprenoid molecules leads to a challenging, expensive, and environmentally unfriendly chemical synthesis of these metabolites. In addition, the awareness and desire of many consumers for products generated by natural microbial processes has increased recently. Metabolic engineering tools and synthetic biology strategies have been used as a means for the enhancement and optimization of the natural isoprenoid biosynthetic pathways of wild strains. Microalgae as production organisms have been manipulated for the bioproduction of diverse isoprenoids. Particularly when cultivated in unsuitable conditions (such as wastewater, unbalanced nutritional sources, and distinct environmental conditions), microalgae can adjust their metabolic pathways and generate compounds with significant technological potential. Several metabolic engineering approaches have been developed, modifying the metabolic pathways in microalgae to redirect the flow of carbon toward isoprenoid biosynthesis, including pathway engineering, strain improvement, and synthetic biology. In this review, some beneficial features of these high-value metabolites are summarized. Besides, recent advancements in metabolic engineering approaches for the biosynthesis of isoprenoids are discussed in detail. At last, the viewpoints and challenges for the biosynthesis of novel compositions with isoprene units in the microalgae are also included.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.